Physician

Preventive Medicine

Ann M. Borzecki works in the field of Preventive Medicine. Borzecki is a published doctor and has 43 publications published. The lastest was: 'Response to: 'Misinterpretation of meaning and intended use of potentially preventable readmissions' by Goldfield et al.'

Publications

---

• Response to: 'Misinterpretation of meaning and intended use of potentially preventable readmissions' by Goldfield et al.
• Measuring readmissions after surgery: do different methods tell the same story?
• Partnering With VA Stakeholders to Develop a Comprehensive Patient Safety Data Display: Lessons Learned From the Field.
• Using Estimated True Safety Event Rates versus Flagged Safety Event Rates: Does It Change Hospital Profiling and Payment?
• Detecting adverse events in surgery: comparing events detected by the Veterans Health Administration Surgical Quality Improvement Program and the Patient Safety Indica...
• Comparison of the Agency for Healthcare Research and Quality Patient Safety Indicator Rates Among Veteran Dual Users.
• The role of comorbidities in patients' hypertension self-management.
• Comparing 2 Methods of Assessing 30-Day Readmissions: What is the Impact on Hospital Profiling in the Veterans Health Administration?
• Improving the identification of Postoperative Wound Dehiscence missed by the Patient Safety Indicator algorithm.
• Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research.
• Development and Testing of Tools to Detect Ambulatory Surgical Adverse Events.
• The role of patients' explanatory models and daily-lived experience in hypertension self-management.
• Examining the Impact of the AHRQ Patient Safety Indicators (PSIs) on the Veterans Health Administration: The Case of Readmissions.
• Is development of postoperative venous thromboembolism related to thromboprophylaxis use? A case-control study in the Veterans Health Administration.
• Excess Costs Attributable to Postoperative Complications.
• How Valid is the AHRQ Patient Safety Indicator "Postoperative Physiologic and Metabolic Derangement"?
• Validity of the AHRQ Patient Safety Indicator "Central Venous Catheter-Related Bloodstream Infections"
• Detecting Patient Safety Indicators: How Valid Is "Foreign Body Left During Procedure" in the Veterans Health Administration?
• Positive Predictive Value of the AHRQ Patient Safety Indicator "Postoperative Wound Dehiscence"
• Positive Predictive Value of the AHRQ Patient Safety Indicator "Postoperative Sepsis": Implications for Practice and Policy.
• How valid is the AHRQ Patient Safety Indicator "postoperative hemorrhage or hematoma"?
• How valid is the AHRQ Patient Safety Indicator "postoperative respiratory failure"?
• Designing an abstraction instrument: lessons from efforts to validate the AHRQ patient safety indicators.
• Validity of selected Patient Safety Indicators: opportunities and concerns.
• Comparison of in-hospital versus 30-day mortality assessments for selected medical conditions.
• Trends in the inpatient quality indicators: the Veterans Health Administration experience.
• Racial differences in the prevalence of atrial fibrillation among males.
• Blood pressure and survival in the oldest old.
• The effect of age on hypertension control and management.
• Management of hypertension and diabetes: treatment goals, drug choices, current practice, and strategies for improving care.
• Barriers to hypertension control.
• Do poor health behaviors affect health-related quality of life and healthcare utilization among veterans? The Veterans Health Study.
• Identifying hypertension-related comorbidities from administrative data: what's the optimal approach?
• Can we use automated data to assess quality of hypertension care?
• Hypertension control: how well are we doing?
• Validity of ICD-9-CM codes for the identification of complications related to central venous catheterization.
• Validating the patient safety indicators in the Veterans Health Administration: do they accurately identify true safety events?
• Mortality risk stratification in chronic kidney disease: one size for all ages?
• Survival in end stage renal disease: calcium carbonate vs. sevelamer.
• The epidemiology and management of severe hypertension.
• Should noncardiac chest pain be treated empirically? A cost-effectiveness analysis.
• Does Use of a Hospital-wide Readmission Measure Versus Condition-specific Readmission Measures Make a Difference for Hospital Profiling and Payment Penalties?

Schools

---

• Faculty Of Health Sciences University Of Ottawa

• Dalhousie University Halifax

Doctors Specialties

---

• Internal Medicine
• Preventive Medicine

Accepted Insurances

---

Education

---

• Boston University Medical Center
• University of Ottawa Faculty of Medicine

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Joseph A. Denagy, DO
	Dr. William J. Porell Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Raghavan Amarasingham, MD
	Dr. Frederick H. Hofheinz, MD This Doctor is OpenDoctor Recommended.
	Dr. Allen L. Gifford, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Thomas S. Bowman, MD This Doctor is OpenDoctor Recommended.
	Dr. Svetlana K. Droznin, MD This Doctor is OpenDoctor Recommended.
	Dr. Alan W. Jenest, MD
	Dr. Benjamin G. Fincke, MD This Doctor is OpenDoctor Recommended.
	Dr. Lakshmi Kona, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog